Delivery Order SPE2DB20D9153-SPE2DB24FF22A
Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $5.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,764.68 firm fixed-price delivery order is for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency...
- This federal contract award, valued at $2,881.04, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Under this single-award IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,762.08 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccine. This order is part of a larger indefinite delivery contract valued up to $4,999,999 that DMS Pharmaceutical Group holds with DLA through 2025 to provide a range of pharmaceutical products to military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,762.08, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and a completion date of May 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,202.60 order is for VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, contract SPE2DB valued up to $4,999,999 through 2025, enabling DLA to place delivery orders for a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $8,643.12 firm fixed-price contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S0ML, with a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which enables DLA to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $16,645.64, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.S ML vaccine. The contract has a completion date of March 4, 2024 and was awarded on March 1, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the Defense...
- This is a $5,762.08 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a performance period ending on February 13, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with the DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,440.52 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,881.04 contract has a performance period running through May 13, 2024. The order is placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA's Medical Supply Chain division, which supports recurring pharmaceutical and medical supply needs for military...
- SPE2DB20D9153Indefinite Delivery Contract
- SPE2DB20D9153-SPE2DB24FF22ADelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,762.08 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The IDC, under the SPE2DB program, has an ultimate completion date of April 19, 2024. This contract award does not have a set-aside designation.
Generated 7/18/24, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/18/24 |